secwatch.observer — SEC 8-K summary
======================================

Issuer:     BRISTOL MYERS SQUIBB CO (BMY)
CIK:        0000014272
Form:       8-K
Filed at:   2023-04-27T23:59:59+00:00
Accession:  0000014272-23-000102
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bristol Myers Q1 revenue $11.3B, GAAP EPS $1.07, Non-GAAP $2.05; affirms non-GAAP guidance
--------------------------------------------------------------------------------

- Q1 2023 revenues $11.3B, down 3% YoY; in-line & new product portfolio grew 8% (10% ex-FX).
- GAAP diluted EPS $1.07 (up 81% YoY); Non-GAAP EPS $2.05 (up 5% YoY).
- Net impact from acquired IPRD charges and licensing income was ($0.01) per share on both GAAP and non-GAAP.
- Company adjusts GAAP 2023 EPS guidance; affirms non-GAAP financial guidance for 2023.
- CEO Giovanni Caforio cites strong commercial execution and milestone achievements in pipeline.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/14272/000001427223000102/0000014272-23-000102-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/14272/000001427223000102/bmy-20230427.htm
  HTML page:      https://secwatch.observer/filing/0000014272-23-000102

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer